Shannon Thyme Klinger serves as Executive at Rafael Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Shannon Thyme Klinger has executed 60 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved selling 22,817 shares valued at $581.6K.
Shannon Thyme Klinger currently holds 53,231 shares of Rafael Holdings, Inc. (RFL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shannon Thyme Klinger has been a net seller of RFL stock. They have purchased $0 and sold $2.0M worth of shares.
Shannon Thyme Klinger's most recent insider trade was on Dec 5, 2025, when they sold 22,817 shares at $25.49 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 1, 2025 | MRNA | $0 | Option Exercise | 233 | $N/A | Discretionary |
| Dec 1, 2025 | MRNA | $2.9K | Payment | 113 | $25.98 | Discretionary |
| Nov 28, 2025 | MRNA | $4.0K | Payment | 160 | $25.01 | Discretionary |
| Nov 28, 2025 | MRNA | $0 | Option Exercise | 329 | $N/A | Discretionary |
| Nov 26, 2025 | MRNA | $0 | Option Exercise | 773 | $N/A | Discretionary |
| Nov 26, 2025 | MRNA | $9.3K | Payment | 374 | $24.75 | Discretionary |
| Aug 29, 2025 | MRNA | $0 | Option Exercise | 232 | $N/A | Discretionary |
| Aug 29, 2025 | MRNA | $2.8K | Payment | 113 | $24.47 | Discretionary |
| Aug 28, 2025 | MRNA | $0 | Option Exercise | 329 | $N/A | Discretionary |
| Aug 28, 2025 | MRNA | $4.0K | Payment | 160 | $25.10 | Discretionary |
| Aug 27, 2025 | MRNA | $9.3K | Payment | 375 | $24.73 | Discretionary |
| Aug 27, 2025 | MRNA | $0 | Option Exercise | 774 | $N/A | Discretionary |
| Sep 9, 2024 | MRNA | $40.5K | Sale | 551 | $73.57 | Planned |
| Sep 6, 2024 | MRNA | $0 | Option Exercise | 1,139 | $N/A | Planned |
| Sep 3, 2024 | MRNA | $8.8K | Sale | 114 | $76.99 | Planned |
| Aug 30, 2024 | MRNA | $0 | Option Exercise | 233 | $N/A | Planned |
| Aug 29, 2024 | MRNA | $12.6K | Sale | 162 | $78.03 | Planned |
| Aug 28, 2024 | MRNA | $104.7K | Sale | 1,319 | $79.39 | Planned |
| Aug 28, 2024 | MRNA | $0 | Option Exercise | 329 | $N/A | Planned |
| Aug 27, 2024 | MRNA | $0 | Option Exercise | 2,652 | $N/A | Planned |
| Jun 10, 2024 | MRNA | $766.8K | Sale | 5,178 | $148.09 | Planned |
| Jun 7, 2024 | MRNA | $0 | Option Exercise | 9,108 | $N/A | Planned |
| Jun 7, 2024 | MRNA | $0 | Option Exercise | 1,139 | $N/A | Planned |
| Jun 3, 2024 | MRNA | $17.2K | Sale | 122 | $140.72 | Planned |
| May 31, 2024 | MRNA | $0 | Option Exercise | 232 | $N/A | Planned |
| May 29, 2024 | MRNA | $26.4K | Sale | 183 | $144.50 | Planned |
| May 28, 2024 | MRNA | $210.6K | Sale | 1,296 | $162.47 | Planned |
| May 28, 2024 | MRNA | $0 | Option Exercise | 328 | $N/A | Planned |